Adage Capital Partners’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Adage Capital Partners’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-109,327	Closed	-$431K	–	766
2016 Q2	$431K	Sell	109,327 -290,673	-73%	-$1.09M	﹤0.01%	670
2016 Q1	$1.24M	Hold	400,000	–	–	﹤0.01%	658
2015 Q4	$1.83M	Hold	400,000	–	–	﹤0.01%	651
2015 Q3	$1.88M	Hold	400,000	–	–	0.01%	678
2015 Q2	$2.86M	Buy	400,000 +125,000	+45%	+$940K	0.01%	668
2015 Q1	$2.33M	Buy	275,000 +40,558	+17%	+$345K	0.01%	669
2014 Q4	$2.18M	Buy	234,442 +159,442	+213%	+$1.39M	0.01%	668
2014 Q3	$625K	Sell	75,000 -75,000	-50%	-$695K	﹤0.01%	695
2014 Q2	$1.73M	Sell	150,000 -123,661	-45%	-$1.27M	﹤0.01%	660
2014 Q1	$3.47M	Buy	+273,661	New	+$3.54M	0.01%	620

Other funds holding DSCI

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Adage Capital Partners's DSCI Position: Q3 2016 in Review

Adage Capital Partners sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q3 2016, closing a stake of 109,327 shares — an estimated $431K sold.

Adage Capital Partners first reported a position in DSCI in Q1 2014 and held it in 10 quarters. The position peaked at $3.47M in Q1 2014. 61 funds tracked by Wall St. Rank hold DSCI as of Q3 2016.

Adage Capital Partners reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q3 2016 after selling out during the quarter.
Adage Capital Partners sold 109,327 Derma Sciences, Inc. Common Stock (DE) shares in Q3 2016, an estimated $431K.
Adage Capital Partners first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q1 2014 and held it in 10 quarters.
Adage Capital Partners's Derma Sciences, Inc. Common Stock (DE) position peaked at $3.47M in Q1 2014.
61 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q3 2016.

Based on Adage Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.